Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Muras

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Dentistry Journal|April 26, 2024
Do Concurrent Peri-Implantitis and Periodontitis Share Their Microbiotas? A Pilot StudyAna Parga, José Manuel Pose-Rodríguez, Andrea Muras, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2024
Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumanniiPatricia García, Paula Guijarro-Sánchez, Cristina Lasarte-Monterrubio, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2025
Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitorsMichelle Outeda-García, Jorge Arca-Suárez, Emilio Lence, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Dentistry Journal|April 26, 2024
Do Concurrent Peri-Implantitis and Periodontitis Share Their Microbiotas? A Pilot StudyAna Parga, José Manuel Pose-Rodríguez, Andrea Muras, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2024
Activity and resistance mechanisms of the third generation tetracyclines tigecycline, eravacycline and omadacycline against nationwide Spanish collections of carbapenemase-producing Enterobacterales and Acinetobacter baumanniiPatricia García, Paula Guijarro-Sánchez, Cristina Lasarte-Monterrubio, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2025
Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitorsMichelle Outeda-García, Jorge Arca-Suárez, Emilio Lence, et al.
Pageof 3